News

  • Feb 2019

    Coriell Institute for Medical Research Expands Leadership Team, Announces New Hires

    The Coriell Institute for Medical Research today announced it is expanding its leadership team by welcoming two skilled scientists to fill two new roles. Jaroslav Jelinek, M.D., Ph.D., will serve as the Institute’s new Chief Research Officer and Jozef Madzo, Ph.D., will join the Institute as its new Director of Bioinformatics. Both are scheduled to start on Feb. 28.

    read more

  • Jan 2019

    Jean-Pierre Issa, MD, Expert in Cancer Epigenetics, to Lead Coriell Institute for Medical Research as President and Chief Executive Officer

    Jean-Pierre Issa, MD, a world-renowned expert in the epigenetics of cancer and director of Temple University’s Fels Institute for Cancer Research and Molecular Biology, will join the Coriell Institute for Medical Research as its new President and Chief Executive Officer, Coriell’s Board of Trustees Chairman Robert Kiep, III, announced today. His first day is scheduled for February 28, 2019.

    read more

  • Dec 2018

    Individuals with Slower Ibuprofen Metabolism Can Self-adjust Dosage

    New research from scientists at the Coriell Institute for Medical Research shows that some individuals whose bodies metabolize ibuprofen more slowly – causing the drug to be present at higher levels than intended – intuitively self-correct their dose without knowing their genetic makeup.

    read more

  • Nov 2018

    Camden Institutions Partner to Research Genetic and Biological Factors to Fight Opioid Addiction

    The Coriell Institute for Medical Research, Cooper University Health Care and Cooper Medical School of Rowan University (CMSRU) are launching the Camden Opioid Research Initiative (CORI), a first-of-its-kind undertaking to investigate the genetic and biological factors that contribute to the development of opioid use disorder (also referred to as opioid dependence or addiction). Opioid overdoses continue to climb in New Jersey and nationally and the opioid addiction epidemic is one of the most urgent public health concerns of our time. This year is the deadliest year of this epidemic in the Garden State.

    read more

  • Aug 2018

    CPMC Researchers to Present Findings at Military Health System Research Symposium

    Researchers from the Coriell Institute for Medical Research will present preliminary research findings at the Military Health System Research Symposium (MHSRS) in Kissimmee, Florida this week. The Coriell scientists will disclose and discuss their work through both posters and breakout session presentations.

    read more

  • Aug 2018

    Coriell Institute for Medical Research Expands Executive Leadership and Announces Promotions

    Coriell Institute for Medical Research today announced the promotion of two of its scientists to new leadership roles. Alissa Resch, PhD, is now the Institute’s Chief Scientific Officer and Nahid Turan, PhD, is now Chief Laboratory Officer. Drs. Resch and Turan previously served as Director of Biobanking Operations and Director of Laboratory Operations, respectively.

    read more

  • Jul 2018

    Coriell Institute for Medical Research Quality Management Earns Updated ISO 9001:2015 Certification

    Coriell’s system is designed to identify and monitor internal and external factors that impact operations and understand the needs and expectations of all interested parties. The system follows the Plan-Do-Check-Act (PDCA) cycle and monitors the performance of all operations tied to quality and customer satisfaction.

    read more

  • Feb 2018

    Rare NGLY1 Mutation Samples Now Available from Coriell Institute for Medical Research

    The Coriell Institute for Medical Research is proud to announce the release of new samples representing N-glycanase deficiency, caused by a mutation on the NGLY 1 gene, also known as Congenital Disorder of Deglycosylation (CDDG). These extraordinarily well characterized samples come from the National Human Genome Research Institute (NHGRI) Undiagnosed Disease Program (UDP) and will be distributed from the National Institute for General Medical Sciences (NIGMS) Human Genetic Cell Repository (HGCR) housed at Coriell.

    read more

  • Jan 2018

    Coriell Institute Mourns the Passing of President and CEO, Michael Christman, PhD

    The Coriell Institute for Medical Research is deeply saddened to announce the sudden passing of its President and CEO, Michael Christman, PhD.

    read more

  • Oct 2017

    Research in Progress: Coriell Team Finds Novel Genetic Variant Associated with Stroke Risk

    Stefan Zajic, PhD, a principal research scientist at the Coriell Institute for Medical Science, will present at the upcoming American Society for Human Genetics’ annual meeting preliminary findings reporting a new gene variant that correlates to increased risk for stroke. The study also suggests that daily aspirin treatment reduces or eliminates the risk for those with the variant.

    read more